María B Birkisdóttir
María B Birkisdóttir
1
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2
Oncode Institute, Utrecht, Netherlands
1,2,
Ivar van Galen
Ivar van Galen
1
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2
Oncode Institute, Utrecht, Netherlands
1,2,
Renata M C Brandt
Renata M C Brandt
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
3,
Sander Barnhoorn
Sander Barnhoorn
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
3,
Nicole van Vliet
Nicole van Vliet
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
3,
Claire van Dijk
Claire van Dijk
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
4
Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
3,4,
Bhawani Nagarajah
Bhawani Nagarajah
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,
Sandra Imholz
Sandra Imholz
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,
Conny T van Oostrom
Conny T van Oostrom
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,
Erwin Reiling
Erwin Reiling
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,
Ákos Gyenis
Ákos Gyenis
6
Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany
6,
Pier G Mastroberardino
Pier G Mastroberardino
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
7
IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy
8
Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Italy
3,7,8,
Dick Jaarsma
Dick Jaarsma
9
Department of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands
9,
Harry van Steeg
Harry van Steeg
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,
Jan H J Hoeijmakers
Jan H J Hoeijmakers
1
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2
Oncode Institute, Utrecht, Netherlands
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
6
Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany
1,2,3,6,
Martijn E T Dollé
Martijn E T Dollé
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
5,*,
Wilbert P Vermeij
Wilbert P Vermeij
1
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2
Oncode Institute, Utrecht, Netherlands
1,2,*
1
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2
Oncode Institute, Utrecht, Netherlands
3
Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
4
Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
5
Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands
6
Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany
7
IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy
8
Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Italy
9
Department of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands
✉*Correspondence: Wilbert P. Vermeij, W.P.Vermeij@prinsesmaximacentrum.nl; Martijn E. T. Dollé, Martijn.Dolle@rivm.nl
This article was submitted to Interventions in Aging, a section of the journal Frontiers in Aging
Received 2022 Nov 1; Accepted 2022 Nov 3; Collection date 2022.
Keywords: aging, DNA damage repair, anti-aging interventions, pharmacological screening, dietary restriction mimetics, NAD, progeria
Copyright © 2022 Birkisdóttir, van Galen, Brandt, Barnhoorn, van Vliet, van Dijk, Nagarajah, Imholz, van Oostrom, Reiling, Gyenis, Mastroberardino, Jaarsma, van Steeg, Hoeijmakers, Dollé and Vermeij.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.